|CRDAMC Homepage | CRDAMC Library Phone #: (254) 288-8366 | CRDAMC Library Fax #: (254) 288-8368|
Treatments for Myelodysplastic Syndrome (MDS)
by Ricker Polsdorfer, MD
Overall, treatment for MDS is focused on destroying cancer cells and slowing disease progression. A stem cell transplant is considered the only way to cure MDS, but it may not work for everyone. Chemo- and radiation therapies may be used to help manage symptoms or in conjunction with stem cell transplant to clear the body of any cancer cells.
If MDS is found in later stages, treatment will focus on supportive care to ease symptoms. These steps will extend life and improve quality of life. These treatment may also slow the progression of certain MDS to acute myeloid leukemia (AML). Supportive care generally includes blood transfusions and medications to boost blood cell counts into a normal range.
The healthcare team will be made up of a variety of health professionals including doctors, surgeons, nurses, and pharmacists. It is important to maintain contact with your medical team, adhere to recommended treatment, and go to any recommended appointments for best outcomes possible.
MDS treatment may include:
Research studies help to determine whether or not new treatments are both safe and effective. If current treatment is not effective for your type of cancer you may wish to ask your doctor if you should consider participating in a clinical trial. You can find out about clinical trials at the http://www.clinicaltrials.gov/ website.
Myelodysplastic syndrome. EBSCO DynaMed Plus website. Available at: http://www.dynamed.... Updated January 13, 2017. Accessed June 30, 2017.
Myelodysplastic syndrome. Merck Manual Professional Version website Available at:
...(Click grey area to select URL)
Updated January 2017. Accessed June 30, 2017.
Treating myelodysplastic syndromes. American Cancer Society website. Available at: https://www.cancer.org/cancer/myelodysplastic-syndrome/treating.html. Accessed June 30, 2017.
Treatment option overview. National Cancer Institute website. Available at: https://www.cancer.gov/types/myeloproliferative/patient/myelodysplastic-treatment-pdq#section/_49. Updated August 12, 2015. Accessed June 30, 2017.
Last reviewed June 2017 by EBSCO Medical Review Board Mohei Abouzied, MD, FACP
Last Updated: 6/24/2016
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.